Aboul-Fettouh clarifies the broad meaning of "alopecia" as a category, distinguishes alopecia areat as an autoimmune subtype, and addresses common patient misconceptions-including misplaced self-blame-that complicate early education and care.

Aboul-Fettouh describes the protracted path many patients travel before receiving a correct AA diagnosis-often 6 to 12 months or longer-and explains the psychosocial weight that accumulates during that delay.

Aboul-Fettouh addresses a persistent misconception among referring clinicians-that AA hair loss will resolve spontaneously-and makes the case for earlier referral and treatment initiation to preserve the greatest opportunity for hair regrowth.

Aboul-Fettouh walks through the clinical and patient-centered factors that move a patient from localized, monitored disease to systemic JAK-inhibitor therapy, emphasizing that SALT score thresholds from clinical trials do not define the real-world trigger for treatment escalation.

Aboul-Fettouh reviews the 3 FDA-approved JAK inhibitors for alopecia areata, highlighting key differentiators-age indication, dosing convenience, renal and hepatic adjustment requirements, and the potential to switch agents when initial therapy fails to achieve adequate regrowth.

Aboul-Fettouh recounts a case in which an incidental skin examination revealed longstanding, undertreated AA in a patient who had been told no effective therapy existed, illustrating how the new generation of JAK inhibitors can restore both hair and hope.

Aboul-Fettouh outlines the documentation strategies, appeal pathways, and manufacturer resources that dermatology practices can leverage to overcome payer barriers and get patients with alopecia areata onto the systemic therapies they need.

Aboul-Fettouh outlines his follow-up schedule for patients on JAK inhibitors, explains why he defers any meaningful hair-regrowth conversation until at least 6 months into therapy, and reflects on the reward of guiding patients through a treatment journey that was unavailable to them just a few years ago.